Drug Development | Kisaco Research

Drug Development

Drug Development

Color: 
#1d3459
  • How phones evolved into a platform for telehealth and the landscape of innovations.
  •  Examples of AI-driven screenings, wearable integration, and remote monitoring.
  • The impact on underserved communities, women’s health, rural access, global health and addressing digital divide challenges.
Digital Health
Med Device
Drug Development
Innovation and Investment

Author:

Shawna Slack

Chief Strategy Officer
Monere
... read more

Shawna Slack

Chief Strategy Officer
Monere
  • Discover how real-world data, genomics, and AI are revealing new targets and mechanisms in female-specific and reproductive conditions.
  • Learn how data integration is shortening timelines from target identification to preclinical validation.
  • Sharing insights into novel drug discovery approaches, the use of AI, multi-omics data, and 3D models.
Reproductive Health
Drug Development

Author:

Stasa Stankovic

Chief Executive Officer
OvartiX
... read more

Stasa Stankovic

Chief Executive Officer
OvartiX
  • Explore the mechanism of action and preclinical efficacy of a first-in-class oncolytic peptide targeting triple negative breast cancer (TNBC).
  • Understand how peptide-based approaches offer new hope for aggressive and treatment-refractory subtypes of breast cancer.
  • Learn about the breast cancer therapeutic roadmap and landscape.
Oncology
Drug Development

Author:

Mark Eccleston

Chief Executive Officer
ValiRx
... read more

Mark Eccleston

Chief Executive Officer
ValiRx
  • Learn how to align clinical development strategies with licensing milestones to accelerate commercialization in women’s health.
  • Explore what pharma and late stage investors look for in licensing-ready assets, from early efficacy signals to regulatory preparedness.
  • Understand how to navigate clinical, legal, and market access challenges unique to women’s health to build a compelling licensing case.
Drug Development

Author:

Oliver Bates

Chief Executive Officer
Viramal
... read more

Oliver Bates

Chief Executive Officer
Viramal
  • Sharing the role of technology and partnerships in the design & recruitment of studies.
  • Highlighting adaptive trial designs, decentralized models, and inclusive recruitment strategies.
  • Exploring how smarter trial design accelerates approval, reduces risk, and improves real-world outcomes.
Reproductive Health
Drug Development
Med Device
  • Discuss strategies for trial design that account for hormonal fluctuations, comorbidities, and age-related variables unique to the menopausal transition.
  • Highlight regulatory, industry, and advocacy efforts that are pushing for menopause-specific representation in therapeutic areas beyond just women’s health.
  • Sharing advancements to educate clinical trial patients about menopause.
Menopause and Longevity
Drug Development
  • Understanding FDA approval pathways for women's health drugs and devices.
  • Addressing regulatory gaps and challenges in clinical trial design and data collection.
  • Strategies for working with regulators to accelerate innovation and ensure patient safety.
Drug Development
Med Device